openPR Logo
Press release

Biosimilar Industry Have Made 3.5 Billion USD and Growing With 27.0% CAGR With Bharat Serums, Bio Sidus, Biogen, BioXpress Therapeutics, Boehringer Ingelheim, Cipla, Emcure Pharmaceuticals, GeneScience and Many More

04-24-2018 02:41 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Biosimilar Market

Biosimilar Market

Market Definition: Global Biosimilar Market

A biosimilar (called as follow-on biologic and subsequent entry biologic) is a biologic medical product that ispractically an identical copy of an original product that is man-made.Biosimilars are made only when the patent for the original product gets expired.Guidelines for biosimilars play a major role in retaining the viability and stability between original and biosimilars products. Numerous regulatory authorities which includeEMA and FDA actively regulate the biosimilars commercialization and development.

The Global Biosimilar Market accounted to USD 3.5 billion in 2016 growing at a CAGR of 27.0% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Get Free Sample Research Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-biosimilar-market

Major Market Drivers:

• Demand of polyurethane in the building and construction industry
• Increasing demand for rigid foam mainly for insulation purposes

Market Restraint:

• Volatility in raw material prices

Market Segmentation: Global Biosimilar Market

The Biosimilar market is segmented on the basis of type into catalyst, surfactants, fillers and others.

On the basis of application, the market is segmented into flexible foam, rigid foam, adhesive & sealant, coating, elastomer, binders and other.
On the basis of end-user, the market is segmented into automotive, building & construction, and bedding & furniture and other.

On the basis of geography, the Biosimilar market report covers data points for 28 countries across multiple geographies such as North America, South America, Europe, Asia-Pacific and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among Major market Drivers and Restraints:

• Increasing Incidence Of Chronic Diseases

• Costly Patented Drugs

• Expanding Geriatric Population

• Technological and Procedural Restrictions

• Nonexistence Of Supervisory Rules

• Customers Brand Inclinations

Market Segmentation: Global Biosimilar Market

By product the global biosimilar market is segmented into recombinant non-glycosylated proteins, recombinant peptides, and recombinant glycosylated proteins.

Recombinant non-glycosylated proteins are further segmented into recombinant human growth hormone (RHGH),insulin, granulocyte colony-stimulating factor (Filgrastim), and interferons.

Recombinant Glycosylated Proteins are again bifurcated into monoclonal antibodies (MABS), erythropoietin (EPO), and follitropin.

Recombinant Peptidesare again divided into glucagon and calcitonin.
On the basis oftypes global biosimilar market is segmented intohuman growth hormone, erythropoietin, monoclonal antibodies, insulin, interferon, granulocyte-colony stimulating factor, and peptide.

On the basis ofthe manufacturingglobal biosimilar market is segmented intocontract manufacturing organizations and in-house manufacturing.
On the basis ofthe application global biosimilar market is segmented intooncology, chronic and autoimmune diseases, blood disorders, growth hormone deficiency, infectious diseases and others.

On the basis of end-user the global biosimilar market is segmented into retail pharmacies, and hospitals.

On the basis of geography, global biosimilar market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Speak to Research Analyst for Further Query: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-biosimilar-market

Competitive Analysis: Global Biosimilar Market

The global biosimilar market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of biosimilar market for global, Europe, North America, Asia Pacific and South America.

Major Market Competitors: Global Biosimilar Market

Some of the major players operating in global biosimilar market are 3SBio Inc., Allergan, Amgen Inc., AstraZeneca, Baxter, Bharat Serums, Bio Sidus, Biogen, BioXpress TherapeuticsSA., Boehringer Ingelheim GmbH, Cipla Inc., Emcure Pharmaceuticals Ltd., GeneScience Pharmaceuticals Co., Ltd., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd, Samsung BioLogics, Sanofi, and Zydus Cadila among others

Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-biosimilar-market

About Us
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
http://databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimilar Industry Have Made 3.5 Billion USD and Growing With 27.0% CAGR With Bharat Serums, Bio Sidus, Biogen, BioXpress Therapeutics, Boehringer Ingelheim, Cipla, Emcure Pharmaceuticals, GeneScience and Many More here

News-ID: 1028762 • Views: 583

More Releases from Data Bridge Market Research

Tumor Ablation Market to Rise at a Highest CAGR of 13.80% With EDAP TMS, HealthT …
Data Bridge Market Research recently published Global Tumor Ablation Market study with an in-depth overview, describing the Product / Industry Scope and elaborates market outlook and status to 2026. The market Study is segmented by key regions that are accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are AngioDynamics, Boston Scientific Corporation, EDAP TMS, HealthTronics, Inc., Medtronic,
Advanced Visualization Market SWOT Analysis and Forecast 2026: GENERAL ELECTRIC …
Global Advanced Visualization Market is having several developments, product launches, joint ventures, mergers and accusations by its prominent market players and top brands which are driving the market in the terms of sales, import, export, and revenue. This report gives an edge to not just compete but to outmatch the competition. The report provides with CAGR value fluctuation during the forecast period of 2018-2025 for the Advanced Visualization Market. This
Pine-Derived Chemicals Market 2019 Analysis: Eastman Chemical Company, Harima Ch …
Data Bridge Market Research recently added Global Pine-Derived Chemicals Market study with an in-depth overview, describing the Product / Industry Scope and elaborates market outlook and status to 2026. The market Study is segmented by key regions which are accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Eastman Chemical Company; Harima Chemicals Group, Inc.; Arakawa Chemical
Hair Accessories Market is Booming at a Highest CAGR of 15.29% With scünci, jdb …
Global Hair Accessories Market Research Report 2019: By Product (Clips & Pins, Head Bands, Wigs & Extensions, Elastics & Ties, Others), Material (Leather, PU, Cloth, Plastics, Metal, Others), Distribution Channel (Supermarkets & Hypermarkets, Multi-Branded Retail Stores, General Stores, Exclusive Retail, Online), End-User (Women, Men), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026 Hair Accessories Market is expected to register a healthy

All 5 Releases


More Releases for Bio

Global Bio Polyurethane (Bio-based Polyurethane) Market 2018 - BASF, Lubrizol
Apex Market Reports, recently published a detailed market research study focused on the “Bio Polyurethane (Bio-based Polyurethane) Market” across the global, regional and country level. The report provides 360° analysis of “Bio Polyurethane (Bio-based Polyurethane) Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend
Global Bioplastics (Bio-plastics,Bio plastics) Market 2018 - Braskem, BASF
Apex Market Reports, recently published a detailed market research study focused on the “Bioplastics (Bio-plastics,Bio plastics) Market” across the global, regional and country level. The report provides 360° analysis of “Bioplastics (Bio-plastics,Bio plastics) Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Bioplastics
Bio Electronics and Bio Sensors Market Forecasts, 2017-2025
Description: The global bio electronic market is valued USD $15 billion in 2016 and is expected to grow at a CAGR of 11.6% during the forecast period 2017-2025. The market is driven by various factors such as rapid advancement in semiconductor technology, high demand in implantable medical devices, increasing prevalence of neural and cardiac diseases among others. The emerging healthcare technologies such as lab on chip, ambulatory surgical centres, and personalized devices are
Bio Simulation Technology Market
Global Bio Simulation Technology Industry Bio Simulation Technology Market is estimated at $1.01 billion in 2015 and is projected to reach $2.99 billion by 2022 growing at a CAGR of 16.6% from 2015 to 2022. Reduction in the cost of drug discovery and development and risk of failure of drug molecule are some of the factors driving the market growth. Furthermore, R&D investments in biotechnology and pharmaceutical industries, growth in the
Global Bio-Polyethylene Terephthalate (Bio-PET) Market Research Report 2021
Qyresearchreports include new market research report “Global Bio-Polyethylene Terephthalate (Bio-PET) Market Research Report 2021″ to its huge collection of research reports. This market intelligence report serves its readers with an executive-level blueprint of the global Bio-Polyethylene Terephthalate (Bio-PET) market. Data from a number of paid and unpaid sources including press releases, journals, presentations, and white papers has been taken into account for collating this report. The various factors influencing the growth of
SHANE RADBONE CORPORATE BIO
Young, dynamic and highly successful Shane founded his own business, Executive Fitness Management at age 20 in 1991. After a successful career in football that took him as high as playing for Essendon, Shane appreciated the need to have more than just sport in his portfolio. However taking his on field attitude to the corporate arena, Executive Fitness Management (EFM) grew into Australia’s largest Corporate Fitness Company. It started with